The role of clobetasol propionate emollient 0.05% in the treatment of patients with dry, scaly, corticosteroid-responsive dermatoses

Clinical Therapeutics

Volumn 20, Issue 1, 1998, Pages 26-39

  Gordon, Marsha L ^a,b  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Clobetasol propionate; Eczema; Emollient; Psoriasis; Topical corticosteroids

Indexed keywords

CETOMACROGOL; CETOSTEARYLIC ALCOHOL; CITRATE SODIUM; CITRIC ACID; CLOBETASOL PROPIONATE; DIMETICONE; EMOLLIENT AGENT; HUMECTANT; MYRISTIC ACID ISOPROPYL ESTER; PRESERVATIVE; PROPYLENE GLYCOL;

ARTICLE; ATOPIC DERMATITIS; CORTICOSTEROID THERAPY; CREAM; DRUG EFFICACY; DRUG FORMULATION; DRUG PENETRATION; DRUG SAFETY; DRUG TOLERABILITY; DRY SKIN; ECZEMA; HUMAN; MOISTURE; PSORIASIS; SKIN INFLAMMATION; TREATMENT INDICATION;

EID: 0031881196     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(98)80032-5     Document Type: Review

References (34)

1. Ramsey DL, Benimoff A. The ability of primary care physicians to recognize the common dermatoses. Arch Dermatol. 1981;117:620-622.
2. Physician Drug and Diagnosis Audit. Scott Levin, January-December 1995. Data on file. Glaxo Wellcome; Research Triangle Park, NC.
3. Larsen FS, Diepgen T, Svensson Å. The occurrence of atopic dermatitis in North Europe: An international questionnaire study. J Am Acad Dermatol. 1996;34: 760-764.
4. Ginsburg IH. Coping with psoriasis: A guide for counseling patients. Cutis. 1996; 57:323-325.
5. Sulzberger MD, Witten VH. The effect of topically applied compound I in selected dermatoses. J Invest Dermatol. 1952;19: 101-102.
6. Stoughton RB, Cornell RC. Review of super-potent topical corticosteroids. Semin Dermatol. 1987;6:72-76.
7. Stoughton RB, Cornell RC. Corticosteroids. In: Fitzpatrick TB, Eisen AZ, Wolff K. et al, eds. Dermatology in General Medicine. New York: McGraw-Hill; 1993: 2846-2850.
8. Fusaro RM, Kingsley DN. Topical glucocorticoids: How they are used and misused. Postgrad Med. 1986;79:283-291.
9. Parish LC, Witkowski JA. Muir JG. Topical corticosteroids. Int J Dermatol. 1985; 24:435-436.
10. Pakes GE, Kamm AR. Topical clobetasol propionate. In: Maibach HI, Surber C, eds. Topical Corticosteroids. Basel, Switzerland: Karger; 1992:370-387.
11. Jacobson C, Cornell RC, Savin RC. A comparison of clobetasol propionate 0.05 percent ointment and an optimized betamethasone dipropionate 0.05 percent ointment in the treatment of psoriasis. Cutis. 1986;37:213-220.
12. Ellis CN, Van Scott EJ. Clobetasol propionate cream versus halcinonide cream in psoriasis. Int J Dermatol. 1986;25: 332-333.
13. Olsen EA, Cram DL, Ellis CN, et al. A double-blind, vehicle-controlled study of clobetasol propionate 0.05% (Temovate) scalp application in the treatment of moderate-to-severe scalp psoriasis. J Am Acad Dermatol. 1991;24:443-447.
14. Björnberg A, Hellgren L. Treatment of psoriasis with clobetasol propionate: A double-blind comparison with betamethasone valerate. Curr Med Res Opin. 1975; 3:36-38.
15. Jegasothy B, Jacobson C, Levine N, et al. Clobetasol propionate versus fluocinonide cream in psoriasis and eczema. Int J Dermatol. 1985;24:461-465.
16. Maloney JM, Morman MR, Stewart DM, et al. Clinical efficacy and safety of an emollient cream formulation of clobetasol propionate in the treatment of moderate to severe atopic dermatitis. Int J Dermatol. In press.
17. Olsen EA, Cornell RC. Topical clobetasol-17-propionate: Review of its clinical efficacy and safety. J Am Acad Dermatol. 1986;15:246-255.
18. Data on file. Glaxo Dermatology; Research Triangle Park, NC; 1997.
19. Elson ML, Terezakis NK. The use of skin-care products and cosmeceuticals in the practice of dermatology. Cosmetic Dermatol. 1994;7:29-32.
20. Jackson EM. Moisturizers of today. J Toxicol Cutaneous Ocul Toxicol. 1992;11: 173-184.
21. Jorizzo JL, Magee K, Stewart DM, et al. Clobetasol propionate emollient 0.05 percent: Hypothalamic-pituitary-adrenalaxis safety and four-week clinical efficacy results in plaque-type psoriasis. Cutis. 1997;60:55-60.
22. Werner YLVA. The water content of the stratum corneum in patients with atopic dermatitis. Acta Derm-Venereol (Stockh). 1986;66:281-284.
23. Nicol NH. Current considerations and management of atopic dermatitis. Dermatol Nurs. 1990;2:129-137.
24. Jackson EM. The science of cosmetics. Am J Contact Dermatitis. 1996;7:247-250.
25. Drake LA, Ceilley RE, Cornelison RL, et al. Guidelines of care for atopic dermatitis. J Am Acad Dermatol. 1992;36:485-488.
26. Watsky KL, Freije L, Leneveu M-C, et al. Water-in-oil emollients as steroid-sparing adjunctive therapy in the treatment of psoriasis. Cutis. 1992;50:383-386.
27. Jackson EM. Latest information on how moisturizers work. Cosmetic Dermatol. 1992;5:35-37.
28. Lowe NJ, ed. Practical Psoriasis Therapy. 2nd ed. Philadelphia: Mosby-Year Book; 1993:54-57.
29. Harvey SC. Topical drugs. In: Gennaro AR, ed. Remington's Pharmaceutical Sciences. 18th ed. Easton, Pa: Mack Publishing; 1990:758.
30. Arndt KA. Manual of Dermatologic Therapeutics. 3rd ed. Boston: Little, Brown; 1984:300-301.
31. Piacquadio DJ. Topical corticosteroids in clinical practice: Focus on fluticasone propionate. Cutis. 1996;57:4-9.
32. Johnson A. Non-steroid skin cream in traumatic dermatoses: A clinical open evaluation. Med J Aust. 1976;1:111-113.
33. Comaish JS, Greener JS. The inhibiting effect of soft paraffin on the Köbner response in psoriasis. Br J Dermatol. 1976; 94:195-200.
34. Harding SM, Sohail S, Busse MJ. Percutaneous absorption of clobetasol propionate from novel ointment and cream formulations. Clin Exp Dermatol. 1985: 10:13-21.